Global Vasopressors Market, By Drugs (Isoproterenol, Phenylephrine, Norepinephrine, Dobutamine, Others), Indication (Bradycardia, Heart Block, Cardiac Arrest, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
Vasopressors Market Analysis and Size
The global vasopressors market is expected to witness significant growth during the forecast period. Emerging markets and huge investment in research and development are the factors responsible for the growth of this market. Factors such as high prevalence of cardiovascular disorders and adopting a sedentary lifestyle are prominent factors driving the global vasopressors market. In addition, launches of drugs annually and improvement in treatment are some of the impacting factors that drives the market growth. COVID-19 also had a major impact on the market growth.
Data Bridge Market Research analyses a growth rate in the global vasopressors market in the forecast period 2022-2029. The expected CAGR of global vasopressors market is tend to be around 15% in the mentioned forecast period. The market was valued at USD 900 million in 2021, and it would grow upto USD 2753.12 million by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Vasopressors are a class of therapeutics that causes vasoconstriction which means narrowing the blood vessels so that blood pressure rapidly increases through the blood vessels. Vasopressors helps in the treatment of cardiovascular disorders such as low blood pressure and cardiac arrest. It is of great importance to the healthcare sector and thus is expected to rise high in the forecast period
Vasopressors Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Drugs (Isoproterenol, Phenylephrine, Norepinephrine, Dobutamine, Others), Indication (Bradycardia, Heart Block, Cardiac Arrest, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Nexus Pharmaceuticals, Inc (U.S.), Cipla Inc (India), Amneal Pharmaceutical Inc (U.K.), Bausch Health (Canada), Pfizer Inc (U.S.), Hikma Pharmaceuticals Inc (U.S.), Eton Pharmaceutical, Inc (U.S.) Norvartis AG (Switzerland), Fresenius Kabi AG (Germany), Akorn Incorporated (U.S.), Teva Pharmaceutical Industries Ltd (Israel), Mylan N.V (U.S.)
|
|
Market Opportunities
|
|
Global Vasopressors Market Dynamics
Drivers
- Increase in Geriatric Population
The geriatric population is expected to increase the patient population globally, which boost the global hematuria treatment market in the forecast period. According to the WHO, the global elderly population is expected to reach around 2 billion by 2050 from 617 million in 2015. This boost the market growth.
- Rising Demand for Oral Drugs
Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.
Opportunities
- Rising Incidence of Hypertension
Higher prevalence of hypertension is expected to boost the market growth. Approximately 21% with hypertension have it under control. Hypertension is a primary cause of premature death worldwide. One of the global targets for non-communicable diseases is to decrease the prevalence of hypertension by 33% between 2010 and 2030. This creates an opportunity of the increase in market growth.
Restraints/Challenges
- Quality Issues
The quality issues associated with manufacturing these devices could curb the growth of the global vasopressors market over a forecast period.
- High Cost
The huge expenditure of these devices surely hamper the market growth.
This global vasopressors market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global vasopressors market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Vasopressors Market Scope
The global vasopressors market is segmented on the basis of drug, indication, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Drugs
- Isoproterenol
- Phenylephrine
- Norepinephrine
- Dobutamine
- Others
Indication
- Bradycardia
- Heart Block
- Cardiac Arrest
- Others
Route of Administration
- Oral
- Parenteral
- Others
End-Users
- Hospitals
- Homecare
- Speciality Centres
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Vasopressors Market Regional Analysis/Insights
The global vasopressors market is analysed and market size insights and trends are provided by drug, indication, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the global vasopressors market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to have the highest market growth due to the high demand of diseases specific treatment, rise in adoption of newer technologies, presence of refined healthcare expenditure and increased patient awareness level as well as high prevalence of cardiovascular disorders.
Asia-Pacific dominates the market due to the presence of global marketed players in this region and growing cases of mental illness.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Vasopressors Market Share Analysis
The global vasopressors market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global vasopressors market
Key players operating in the global vasopressors market include:
- Nexus Pharmaceuticals, Inc (U.S.)
- Cipla Inc (India)
- Amneal Pharmaceutical Inc (U.K.)
- Bausch Health (Canada)
- Pfizer Inc (U.S.)
- Hikma Pharmaceuticals Inc (U.S.)
- Eton Pharmaceutical, Inc (U.S.)
- Norvartis AG (Switzerland)
- Fresenius Kabi AG (Germany)
- Akorn Incorporated (U.S.)
- Teva Pharmaceutical Industries Ltd (Israel)
- Mylan N.V (U.S.)
SKU-